Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Tonix Pharmaceuticals Holding stock

Learn how to easily invest in Tonix Pharmaceuticals Holding stock.

Tonix Pharmaceuticals Holding Corp is a biotechnology business based in the US. Tonix Pharmaceuticals Holding shares (TNXP) are listed on the NASDAQ and all prices are listed in US Dollars. Tonix Pharmaceuticals Holding employs 73 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Tonix Pharmaceuticals Holding

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TNXP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Tonix Pharmaceuticals Holding stock price (NASDAQ: TNXP)

Use our graph to track the performance of TNXP stocks over time.

Tonix Pharmaceuticals Holding shares at a glance

Information last updated 2022-07-02.
Latest market close$1.61
52-week range$1.53 - $35.20
50-day moving average $2.95
200-day moving average $9.69
Wall St. target price$40.67
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-7.50

Buy Tonix Pharmaceuticals Holding shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Tonix Pharmaceuticals Holding stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tonix Pharmaceuticals Holding price performance over time

Historical closes compared with the close of $1.61 from 2022-07-01

1 week (2022-06-27) -9.04%
1 month (2022-06-03) -34.82%
3 months (2022-04-05) 631.82%
6 months (2022-01-05) 360.00%
1 year (2021-07-02) 47.71%
2 years (2020-07-02) 169.01%
3 years (2019-07-05) 27.78%
5 years (2017-07-03) 4.38

Tonix Pharmaceuticals Holding financials

Gross profit TTM $0
Return on assets TTM -30.08%
Return on equity TTM -50.95%
Profit margin 0%
Book value $12.04
Market capitalisation $30.2 million

TTM: trailing 12 months

Tonix Pharmaceuticals Holding share dividends

We're not expecting Tonix Pharmaceuticals Holding to pay a dividend over the next 12 months.

Have Tonix Pharmaceuticals Holding's shares ever split?

Tonix Pharmaceuticals Holding's shares were split on a 1:32 basis on 16 May 2022. So if you had owned 32 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Tonix Pharmaceuticals Holding shares – just the quantity. However, indirectly, the new 3100% higher share price could have impacted the market appetite for Tonix Pharmaceuticals Holding shares which in turn could have impacted Tonix Pharmaceuticals Holding's share price.

Tonix Pharmaceuticals Holding share price volatility

Over the last 12 months, Tonix Pharmaceuticals Holding's shares have ranged in value from as little as $1.53 up to $35.2. A popular way to gauge a stock's volatility is its "beta".

TNXP.US volatility(beta: 1.44)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tonix Pharmaceuticals Holding's is 1.4415. This would suggest that Tonix Pharmaceuticals Holding's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Tonix Pharmaceuticals Holding overview

Tonix Pharmaceuticals Holding Corp. , a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Its rare disease portfolio comprises TNX-2900 for the treatment of Prader-Willi syndrome. The company's infectious disease pipeline includes TNX-801, a vaccine to prevent smallpox and monkeypox; TNX-1840 and TNX-1850 that are live virus vaccines based on its recombinant pox vaccine (RPV) platform for COVID-19; TNX-3500, a small molecule antiviral drug to treat acute COVID-19; and TNX-102 SL, a small molecule drug to treat Long COVID, a chronic post-acute COVID-19 condition. Its CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions, including TNX-102 SL, which is in mid-Phase 3 development for the management of fibromyalgia; TNX-1900 that is in development for the prevention of migraine headache; and TNX-1300, a biologic designed to treat cocaine intoxication.

Frequently asked questions

What percentage of Tonix Pharmaceuticals Holding is owned by insiders or institutions?
Currently 0.067% of Tonix Pharmaceuticals Holding shares are held by insiders and 19.046% by institutions.
How many people work for Tonix Pharmaceuticals Holding?
Latest data suggests 73 work at Tonix Pharmaceuticals Holding.
When does the fiscal year end for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding's fiscal year ends in December.
Where is Tonix Pharmaceuticals Holding based?
Tonix Pharmaceuticals Holding's address is: 26 Main Street, Chatham, NJ, United States, 07928
What is Tonix Pharmaceuticals Holding's ISIN number?
Tonix Pharmaceuticals Holding's international securities identification number is: US8902608624
What is Tonix Pharmaceuticals Holding's CUSIP number?
Tonix Pharmaceuticals Holding's Committee on Uniform Securities Identification Procedures number is: 890260102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site